RE: What is a genuine holder?1 Jan 2025 11:07
Chk1 drugs are being explored by our other competitors, as we speak. We know the combo data is brilliant, as has been highlighted by the cancer specialists. I am sure someone, will take this.
We now concentrate on 1801, and so far has been very good data, efficacy wise, and safety wise.
All the best to all here, the moaners, groaners, and the hampers and derampers.